Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
A yearly strategy formalizes harvest windows, helping you optimize tax outcomes while staying invested in index funds.
22,166 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
A notable fund recently reported a substantial exit in a popular beauty stock. We break down what this move could sig...
Two YieldMax income ETFs tied to Berkshire and Microsoft have seen weekly payouts collapse as market volatility dries...
Quant funds are piloting a data-pruning approach named test delete to improve backtest robustness as markets remain v...
A spotlight on KNG shows it earns an 8.6% yield by selling covered calls on Dividend Aristocrats, but eight-year retu...
Strategy has boosted its Bitcoin holdings again, financing the move by selling stock and growing its asset base. Crit...
Strategy launched its largest BTC sale this week, intensifying the debate over unrealized losses among major crypto h...
A major fund sold almost 230k ANIP shares in Q1, triggering volatility in the pharma stock. This article breaks down ...
ProShares Ultra Silver aimed to double silver's move, but daily resets and volatility trimmed returns, reshaping expe...
Blue (OBDC) 2025 earnings could signal how well the firm leverages private credit trends and cost discipline. This gu...
A 64-year-old mother set up a third-party special needs trust to safeguard her disabled son's government benefits, hi...
New to crypto? This beginner-friendly guide walks you through the top cryptocurrencies for beginners, how to evaluate...